U.S. jury orders Bayer to pay $2.1B in Roundup cancer case

A jury in Georgia has awarded approximately $2.1 billion to a man who claimed that Bayer’s (OTCPK:BAYZF) (OTCPK:BAYRY) Roundup herbicide caused his cancer, marking another major blow to the company in a string of lawsuits that have already